News

• Stifel Bolsters Healthcare Services Investment Banking Team With Three New Managing Directors
  09/15/2020 / 14:30 - GlobeNewswire
•  
• Grifols says its anti-COVID-19 therapeutics ready for trials
  07/28/2020 / 16:58 - TeleTrader
•  
• Alkahest Provides Corporate Update
  07/09/2020 / 13:30 - GlobeNewswire
•  
• Alkahest Announces Initiation of Phase 2 Study AKST1210-201 Exploring Treatment of Cognitive Impairment in End Stage Renal Disease Patients
  06/01/2020 / 13:30 - GlobeNewswire
•  
• Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
  05/28/2020 / 22:01 - GlobeNewswire
•  
• Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer
  04/24/2020 / 14:00 - GlobeNewswire
•  
• GigaGen Initiates Development of Recombinant Polyclonal Antibody Therapy for COVID-19
  03/30/2020 / 16:17 - GlobeNewswire
•  
• Alkahest Announces Initiation of Phase 2b Clinical Trial of AKST4290 in Patients with Treatment-Naïve Wet Age-Related Macular Degeneration
  02/10/2020 / 13:30 - GlobeNewswire
•  
• Alkahest Initiates a Phase 2 Clinical Trial of AKST4290 in Parkinson’s Disease with Funding from The Michael J. Fox Foundation
  02/04/2020 / 13:30 - GlobeNewswire
•  
• BioCryst Strengthens Commercial Rare Disease Leadership
  01/15/2020 / 13:00 - GlobeNewswire
•  
• Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of AKST4290 on Choroidal Blood Flow in Age-Related Macular Degeneration
  12/17/2019 / 13:30 - GlobeNewswire
•  
• Nufactor® Selected by Grifols to be Included in the Limited Network of Specialty Pharmacies for XEMBIFY®
  12/12/2019 / 23:24 - GlobeNewswire
•  
• Alkahest Presents Data from Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease
  12/09/2019 / 13:30 - GlobeNewswire
•  
• Alkahest to Present New Data from Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease at the Clinical Trials in Alzheimer’s Disease (CTAD) Conference
  12/02/2019 / 13:30 - GlobeNewswire
•  
• Global Human Gene Sequencing Markets 2020-2024: Strategies, Trends and Forecasts by Hereditary, Newborn Screening, NIPT, Oncology, Pharmacogenomic, Direct To Consumer & Country
  10/30/2019 / 15:30 - GlobeNewswire